Nurix Therapeutics reported revenue of $9.04M and net income of -$89.53M for the quarter ended May 2026, down 79.5% year over year. This income statement covers 28 quarters of results from Aug 2019 through May 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Aug2019 | Nov2019 | Feb2020 | May2020 | Aug2020 | Nov2020 | Feb2021 | May2021 | Aug2021 | Nov2021 | Feb2022 | May2022 | Aug2022 | Nov2022 | Feb2023 | May2023 | Aug2023 | Nov2023 | Feb2024 | May2024 | Aug2024 | Nov2024 | Feb2025 | May2025 | Aug2025 | Nov2025 | Feb2026 | May2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||
| Revenue | 10.25M | 7.40M | 9.62M | 11.43M | 10.79M | 6.78M | 12.69M | 30.68M | 18.47M | 15.16M | 16.59M | 12.09M | 12.59M | 13.28M | 18.45M | 44.06M | 7.89M | 13.58M | 6.25M | 9.04M | ||||||||
| Operating items | ||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 30.91M | 36.53M | 43.14M | 47.49M | 47.76M | 46.11M | 45.82M | 45.76M | 47.86M | 49.71M | 50.01M | 48.92M | 55.48M | 67.22M | 69.66M | 78.10M | 86.12M | 83.02M | 84.14M | 87.65M | ||||||||
| Selling, General & AdministrativeSG&A | 8.34M | 8.82M | 9.23M | 9.65M | 9.75M | 9.37M | 9.82M | 11.68M | 10.62M | 10.78M | 11.80M | 11.71M | 11.72M | 10.72M | 11.65M | 14.28M | 13.16M | 13.65M | 14.61M | 15.59M | ||||||||
| Operating ExpensesOpex | 39.25M | 45.35M | 52.37M | 57.15M | 57.51M | 55.47M | 55.64M | 57.44M | 58.48M | 60.49M | 61.80M | 60.63M | 67.20M | 77.94M | 81.32M | 92.38M | 99.28M | 96.67M | 98.75M | 103.25M | ||||||||
| Operating IncomeOp. Inc | -29.00M | -37.95M | -42.74M | -45.72M | -46.72M | -48.69M | -42.95M | -26.77M | -40.01M | -45.33M | -45.22M | -48.54M | -54.61M | -64.66M | -62.86M | -48.32M | -91.39M | -83.09M | -92.50M | -94.20M | ||||||||
| EBIT | -29.00M | -37.95M | -42.74M | -45.72M | -46.72M | -48.69M | -42.95M | -26.77M | -40.01M | -45.33M | -45.22M | -48.54M | -54.61M | -64.66M | -62.86M | -48.32M | -91.39M | -83.09M | -92.50M | -94.20M | ||||||||
| Non-operating items | ||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.04M | 0.29M | 0.21M | 0.31M | 1.01M | 1.97M | 2.22M | 2.49M | 3.03M | 3.38M | 3.79M | 4.08M | 5.74M | 6.12M | 6.51M | 5.62M | 4.96M | 4.87M | 5.32M | 4.40M | ||||||||
| Net income details | ||||||||||||||||||||||||||||
| EBT | -28.96M | -37.66M | -42.53M | -45.40M | -45.71M | -46.72M | -40.73M | -24.28M | -36.98M | -41.96M | -41.43M | -44.46M | -48.87M | -58.54M | -56.35M | -42.70M | -86.42M | -78.22M | -87.17M | -89.81M | ||||||||
| Tax ProvisionsTaxes | -0.12M | 0.03M | 0.09M | 0.09M | 0.08M | 0.01M | 0.76M | -0.27M | ||||||||||||||||||||
| Profit After TaxPAT | -28.84M | -37.69M | -42.53M | -45.40M | -45.71M | -46.72M | -40.73M | -24.28M | -36.98M | -41.96M | -41.52M | -44.55M | -48.96M | -58.55M | -56.35M | -43.46M | -86.42M | -78.22M | -87.17M | -89.53M | ||||||||
| Income from Continuing OperationsIncome (Continuing) | -28.84M | -37.69M | -42.53M | -45.40M | -45.71M | -46.72M | -40.73M | -24.28M | -36.98M | -41.96M | -41.52M | -44.55M | -48.96M | -58.55M | -56.35M | -43.46M | -86.42M | -78.22M | -87.17M | -89.53M | ||||||||
| Consolidated Net IncomeConsol Net Inc. | -28.84M | -37.69M | -42.53M | -45.40M | -45.71M | -46.72M | -40.73M | -24.28M | -36.98M | -41.96M | -41.52M | -44.55M | -48.96M | -58.55M | -56.35M | -43.46M | -86.42M | -78.22M | -87.17M | -89.53M | ||||||||
| Income towards Parent CompanyParent Net Inc | -28.84M | -37.70M | -42.53M | -45.40M | -45.71M | -46.72M | -40.73M | -24.28M | -36.98M | -41.96M | -41.52M | -44.55M | -48.96M | -58.55M | -56.35M | -43.46M | -86.42M | -78.22M | -87.17M | -89.53M | ||||||||
| Net Income towards Common StockholdersNet Income | -28.84M | -37.70M | -42.53M | -45.40M | -45.71M | -46.72M | -40.73M | -24.28M | -36.98M | -41.96M | -41.52M | -44.55M | -48.96M | -58.55M | -56.35M | -43.46M | -86.42M | -78.22M | -87.17M | -89.53M | ||||||||
| Additional items | ||||||||||||||||||||||||||||
| EPS (Basic) | -0.65 | -0.88 | -0.95 | -1.01 | -0.90 | -0.96 | -0.75 | -0.45 | -0.68 | -0.77 | -0.76 | -0.71 | -0.67 | -0.87 | -0.67 | -0.52 | -1.03 | -0.90 | -0.79 | -0.81 | ||||||||
| EPS (Diluted) | -0.65 | -0.88 | -0.95 | -1.01 | -0.90 | -0.96 | -0.75 | -0.45 | -0.68 | -0.77 | -0.76 | -0.71 | -0.67 | -0.87 | -0.67 | -0.52 | -1.03 | -0.90 | -0.79 | -0.81 | ||||||||
| Shares Outstanding | 44.37M | 42.90M | 44.69M | 44.90M | 50.87M | 48.61M | 54.03M | 54.26M | 54.39M | 54.34M | 54.90M | 62.38M | 72.78M | 67.12M | 83.56M | 83.88M | 84.16M | 86.67M | 110.07M | 111.08M | ||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 44.37M | 42.90M | 44.69M | 44.90M | 50.87M | 48.61M | 54.03M | 54.26M | 54.39M | 54.34M | 54.90M | 62.38M | 72.78M | 67.12M | 83.56M | 83.88M | 84.16M | 86.67M | 110.07M | 111.08M | ||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 44.56M | 44.66M | 44.85M | 45.04M | 47.15M | 47.17M | 47.44M | 47.63M | 48.50M | 48.72M | 49.14M | 64.36M | 67.08M | 75.87M | 76.23M | 76.43M | 76.87M | 101.81M | 103.40M | 103.70M | ||||||||
| EBITDA | -28.30M | -37.19M | -41.75M | -44.41M | -45.22M | -47.07M | -41.20M | -24.87M | -38.06M | -43.40M | -43.17M | -46.21M | -52.22M | -62.11M | -60.51M | -46.08M | -89.36M | -80.97M | -90.30M | -91.95M |
Pull Nurix Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=NRIX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "NRIX", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/statements?ticker=NRIX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();